VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
KHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KHCThe Kraft Heinz Company
$24.75$29.3B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKHCBalance Sheet

The Kraft Heinz Company (KHC) Balance Sheet

15Y historyFree accessUpdated daily

Total assets fell 19% to $73.1B as goodwill dropped 35% to $19.7B, but debt remains substantial at $19.0B with a D/E of 0.53 that understates true leverage given $13.5B in cumulative impairments reducing equity.

KHC Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Total Current Assets9.25B10.13B7.66B7.93B7.9B8.99B10.82B8.1B9.07B7.2B8.75B9.78B4.79B4.91B4.82B3.27B
Cash & Short-Term Investments2.68B3.67B1.33B1.4B1.04B3.44B3.42B2.28B1.13B1.63B4.2B4.84B1.29B1.69B1.25B0
Cash Only2.42B2.62B1.33B1.4B1.04B3.44B3.42B2.28B1.13B1.63B4.2B4.84B1.29B1.69B1.25B0
Short-Term Investments262M1.06B00000000000000
Accounts Receivable2.29B2.25B2.15B2.11B2.12B1.96B2.06B1.97B2.28B1.81B1.16B1.45B1.08B1.05B1.09B903M
Days Sales Outstanding33.3532.9830.3228.9429.2227.4328.7628.8331.725.3616.0728.9421.652121.7517.74
Inventory3.31B3.17B3.38B3.61B3.65B2.73B2.77B2.72B2.67B2.76B2.68B2.62B1.77B1.62B1.93B1.94B
Days Inventory Outstanding72.6469.573.0174.4772.5757.3859.5159.0156.1259.1157.1175.9848.4951.7656.355.35
Other Current Assets710M740M583M569M846M727M2.44B740M2.6B655M707M871M643M558M551M426M
Total Non-Current Assets63.81B71.66B80.63B82.41B82.62B84.4B89.01B93.35B94.39B112.89B111.73B113.19B18.16B18.24B18.36B18.27B
Property, Plant & Equipment7.2B7.32B7.15B7.12B6.74B6.81B6.88B7.05B7.08B7.06B6.69B6.52B4.19B4.12B4.2B4.28B
Fixed Asset Turnover3.45x3.41x3.61x3.74x3.93x3.83x3.81x3.54x3.71x3.69x3.93x2.81x4.34x4.43x4.35x4.34x
Goodwill19.71B22.18B28.67B30.46B30.83B31.3B33.09B35.55B36.5B44.83B44.13B43.05B11.4B11.51B11.6B11.32B
Intangible Assets32.37B37.53B40.1B42.45B42.65B43.54B46.67B48.65B49.47B59.43B59.3B62.12B2.23B2.23B2.23B2.63B
Long-Term Investments167M0196M112M108M182M0000000000
Other Non-Current Assets4.53B4.63B4.51B2.27B2.29B2.57B2.38B2.1B1.34B1.57B1.62B1.5B326M391M325M43M
Total Assets73.06B81.79B88.29B90.34B90.51B93.39B99.83B101.45B103.46B120.09B120.48B122.97B22.95B23.15B23.18B21.54B
Asset Turnover0.31x0.30x0.29x0.29x0.29x0.28x0.26x0.25x0.25x0.22x0.22x0.15x0.79x0.79x0.79x0.86x
Asset Growth %-34.67%-7.36%-2.27%-0.19%-3.08%-6.45%-1.6%-1.94%-13.85%-0.32%-2.03%435.9%-0.87%-0.13%7.61%-
Total Current Liabilities8.72B8.78B7.25B8.04B9.03B9.06B8.06B7.88B7.5B10.15B9.5B6.93B4.77B3.41B3.61B2.57B
Accounts Payable4.48B4.31B4.19B4.63B4.85B4.75B4.3B4B4.15B4.36B4B2.84B1.54B1.55B1.56B1.45B
Days Payables Outstanding96.8794.5490.5795.3496.3699.9392.3786.8187.3893.4285.0382.5441.9949.5845.4441.22
Short-Term Debt1.38B1.91B654M638M837M754M236M1.03B398M3.19B2.69B83M1.41B4M5M8M
Deferred Revenue (Current)0000000000000000
Other Current Liabilities1.5B1.46B1.45B1.78B2.33B1.94B2.1B1.81B1.82B1.49B1.4B1.57B996M860M1.01B542M
Current Ratio1.06x1.15x1.06x0.99x0.87x0.99x1.34x1.03x1.21x0.71x0.92x1.41x1.00x1.44x1.34x1.27x
Quick Ratio0.68x0.79x0.59x0.54x0.47x0.69x1.00x0.68x0.85x0.44x0.64x1.03x0.63x0.97x0.80x0.52x
Cash Conversion Cycle9.117.9512.768.065.42-15.13-4.11.030.43-8.95-11.8522.3828.1623.1832.6231.87
Total Non-Current Liabilities28.09B31.22B31.71B32.58B32.62B34.88B41.53B41.83B44.18B43.86B53.41B49.8B13.81B14.55B16B2.38B
Long-Term Debt17.62B19.31B19.21B19.39B19.23B21.06B28.07B28.22B30.77B28.31B29.71B25.15B8.63B9.98B9.97B27M
Capital Lease Obligations0000000000000000
Deferred Tax Liabilities35.02B9.02B9.68B10.2B10.15B10.54B11.46B11.88B12.2B14.04B20.85B21.5B340M662M138M1.59B
Other Non-Current Liabilities1.46B1.56B1.44B1.56B1.75B1.75B1.99B1.73B1.21B1.51B2.84B3.16B4.84B3.91B5.9B758M
Total Liabilities36.94B40B38.96B40.62B41.64B43.94B49.59B49.7B51.68B54.02B62.91B56.74B18.58B17.96B19.61B4.95B
Total Debt19B21.22B19.87B20.03B20.07B21.82B28.31B29.24B31.17B31.5B32.4B25.23B10.03B9.98B9.97B35M
Net Debt16.58B18.6B18.54B18.63B19.03B18.37B24.89B26.96B30.04B29.87B28.2B20.4B8.74B8.29B8.72B35M
Debt / Equity0.53x0.51x0.40x0.40x0.41x0.44x0.56x0.57x0.60x0.48x0.56x0.38x2.30x1.92x2.79x0.00x
Debt / EBITDA-9.51x-7.55x3.62x4.39x4.99x9.14x7.20x-4.44x4.67x7.47x4.41x2.00x3.22x0.01x
Net Debt / EBITDA-8.30x-7.04x3.37x4.17x4.20x8.04x6.64x-4.21x4.06x6.04x3.84x1.66x2.81x0.01x
Interest Coverage-4.06x-4.75x1.94x4.98x4.22x1.83x1.74x2.96x-7.82x5.42x5.36x1.77x3.90x9.16x10.51x720.00x
Total Equity36.13B41.79B49.33B49.72B48.87B49.45B50.24B51.75B51.78B66.08B57.57B66.24B4.37B5.19B3.57B16.59B
Equity Growth %-57.65%-15.28%-0.8%1.74%-1.18%-1.57%-2.91%-0.06%-21.64%14.77%-13.08%1417.43%-15.85%45.21%-78.47%-
Book Value per Share30.4635.2140.6040.2639.5740.0140.9142.2842.4853.7746.9684.277.308.665.9728.07
Total Shareholders' Equity36.01B41.66B49.19B49.53B48.68B49.3B50.1B51.62B51.66B65.86B57.36B66B4.37B5.19B3.57B16.59B
Common Stock12M12M12M12M12M12M12M12M12M12M12M12M0000
Retained Earnings-9.29B-4.63B2.17B1.37B489M-1.68B-2.69B-3.06B-4.85B8.49B588M01.04B1.28B-206M0
Treasury Stock-2.65B-2.64B-2.22B-1.29B-847M-587M-344M-271M-282M-224M-207M-31M-796M-29M-2M0
Accumulated OCI-2.46B-2.37B-2.92B-2.6B-2.81B-1.82B-1.97B-1.89B-1.94B-1.05B-1.63B-671M-562M-499M-460M-125M
Minority Interest124M125M140M196M192M154M140M126M121M213M216M231M0000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Impairment-driven earnings volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Shrinking Amid Strategic Reset

Total assets fell from $90.3B in 2025Q1 to $73.1B in 2026Q2, a 19% decline, driven by a $9.1B goodwill impairment and portfolio divestitures, as reported in quarterly filings.

The balance sheet is contracting rapidly, with total liabilities also declining from $40.7B to $36.9B, but equity has dropped more sharply from $49.5B to $36.0B, reflecting the impairment charges. This suggests a deliberate de-risking of the asset base, but the pace of contraction may indicate ongoing portfolio reshaping rather than organic deterioration. Investors should monitor whether further impairments are likely as the company streamlines its brand portfolio.

Leverage Creeps Higher as Debt Persists

Despite a reported D/E of 0.53, total debt of $19.0B remains substantial, and the debt-to-assets ratio has risen from 22.7% in 2024Q1 to 26.0% in 2026Q2, per balance sheet data.

The D/E ratio appears understated because equity has been eroded by impairments, masking the true leverage burden. With total debt stable around $19-21B and equity shrinking, the effective leverage is increasing, which could strain interest coverage if rates remain elevated. The company's ability to service this debt is supported by positive operating cash flow, but the trend warrants monitoring given the planned split and potential covenant pressures.

Goodwill Impairments Reshape Asset Mix

Goodwill dropped from $30.4B in 2024Q1 to $19.7B in 2026Q2, a 35% reduction, while PPE remained flat near $7.2B, indicating a shift toward a more tangible asset base, as per financial statements.

The massive goodwill write-downs reflect a reassessment of brand values, reducing the intangible-heavy balance sheet. This may indicate a more conservative valuation of acquired brands, but it also raises questions about the remaining goodwill's recoverability. The stable PPE suggests ongoing investment in manufacturing capacity, but the overall asset mix is becoming less reliant on intangibles, which could reduce future impairment risk.

Retained Earnings Turn Negative on Impairments

Retained earnings swung from $2.4B in 2025Q1 to -$9.3B in 2026Q2, a $11.7B deterioration, driven by cumulative net losses, as reported in quarterly balance sheets.

The negative retained earnings balance is a direct consequence of the impairment charges, which have wiped out prior accumulated profits. This reduces the equity cushion and may limit financial flexibility, though the company continues to pay dividends, suggesting management views the losses as non-cash and temporary. The equity quality is now weaker, and future profitability will be critical to rebuilding retained earnings.

Liquidity Tightens as Current Ratio Nears 1.0

The current ratio fell from 1.31 in 2025Q1 to 1.06 in 2026Q2, while cash declined from $2.1B to $2.4B, indicating a thinner buffer against short-term obligations, per recent filings.

Liquidity is adequate but tightening, with the current ratio approaching the 1.0 threshold, which could signal difficulty covering short-term liabilities if working capital deteriorates further. Cash levels have been volatile, ranging from $0.9B to $3.5B, and the company's ability to generate operating cash flow remains positive, but the planned split may require additional liquidity. Investors should monitor whether the company can maintain its dividend and fund restructuring without increasing debt.

Impairments Distort Balance Sheet Health

The reported D/E of 0.53 is misleading because equity has been reduced by $13.5B in cumulative impairments, masking the true leverage, as evidenced by the $19B debt load, per balance sheet data.

The headline leverage metrics understate the company's financial risk because the equity base has been eroded by non-cash charges, making the D/E ratio appear artificially low. If impairments were excluded, the D/E would be significantly higher, potentially exceeding 0.8, which would place KHC at a leverage disadvantage relative to peers like GIS and CPB. This distortion suggests that investors should focus on debt-to-EBITDA and interest coverage rather than D/E when assessing credit risk.

KHC — Frequently Asked Questions

Quick answers to the most common questions about buying KHC stock.

What are the total assets of The Kraft Heinz Company (KHC)?

As of 2025, The Kraft Heinz Company (KHC) had total assets of $81.79B including $10.13B in current assets.

How much debt does The Kraft Heinz Company (KHC) have?

The Kraft Heinz Company (KHC) carries total debt of $21.22B, offset by $3.67B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of The Kraft Heinz Company?

The Kraft Heinz Company (KHC) has total shareholders' equity (book value) of $41.66B ($35.21 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is The Kraft Heinz Company's current ratio and liquidity?

The Kraft Heinz Company (KHC) reported a current ratio of 1.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.